{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:04:16Z","timestamp":1793930656345,"version":"4.8.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["310030_152680"],"award-info":[{"award-number":["310030_152680"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["310030_175470\/1"],"award-info":[{"award-number":["310030_175470\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Evidence shows that dysfunctional SSc keratinocytes contribute to fibrosis by altering dermal homeostasis. Whether IL-25, an IL-17 family member regulating many epidermal functions, takes part in skin fibrosis is unknown. Here we address the role of IL-25 in skin fibrosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The expression of IL-25 was evaluated by immunofluorescence and in situ hybridization in 10 SSc and seven healthy donor (HD) skin biopsies. Epidermal equivalents (EE) reconstituted by primary HD keratinocytes were used as a model to study transcriptomic changes induced by IL-25 in the epidermis. RNA expression profile in EEs was characterized by RNAseq. The conditioned medium (CM) from primary SSc and HD keratinocytes primed with IL-25 was used to stimulate fibroblasts. IL-6, IL-8, MMP-1, type-I collagen (Col-I), and fibronectin production by fibroblasts was assessed by ELISA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>SSc epidermis expressed lower levels of IL-25 compared with HDs. In EEs, IL-25 regulated several molecular pathways related to wound healing and extracellular matrix remodelling. Compared with control CM, the CM from IL-25-primed keratinocytes enhanced the fibroblast production of MMP-1, IL-6 and IL-8, but not of Col-I nor fibronectin. However, IL-25 significantly reduced the production of Col-I when applied directly to fibroblasts. The activation of keratinocytes by IL-25 was receptor-dependent and evident after a very short incubation time (10\u2009min), largely mediated by IL-1, suggesting enhanced and specific release of preformed mediators.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These results show that IL-25 participates in skin homeostasis, and its decreased expression in SSc may contribute to skin fibrosis by favouring extracellular matrix deposition over degradation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac044","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T20:27:41Z","timestamp":1644870461000},"page":"4558-4569","source":"Crossref","is-referenced-by-count":10,"title":["IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis"],"prefix":"10.1093","volume":"61","author":[{"given":"Barbara","family":"Russo","sequence":"first","affiliation":[{"name":"Pathology & Immunology, School of Medicine"},{"name":"Department of Dermatology, University Hospital and School of Medicine, University of Geneva , Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Borowczyk","sequence":"additional","affiliation":[{"name":"Pathology & Immunology, School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Cacialli","sequence":"additional","affiliation":[{"name":"Pathology & Immunology, School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moguelet","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tenon Hospital APHP , Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Elise","family":"Truchetet","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital , Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Modarressi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Plastic, Reconstructive & Aesthetic Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2 C","family":"Brembilla","sequence":"additional","affiliation":[{"name":"Pathology & Immunology, School of Medicine"},{"name":"Department of Dermatology, University Hospital and School of Medicine, University of Geneva , Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Bertrand","sequence":"additional","affiliation":[{"name":"Pathology & Immunology, School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf-Henning","family":"Boehncke","sequence":"additional","affiliation":[{"name":"Pathology & Immunology, School of Medicine"},{"name":"Department of Dermatology, University Hospital and School of Medicine, University of Geneva , Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4849-6335","authenticated-orcid":false,"given":"Carlo","family":"Chizzolini","sequence":"additional","affiliation":[{"name":"Pathology & Immunology, School of Medicine"},{"name":"Immunology & Allergy, Department of Internal Medicine, University Hospital and School of Medicine , Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"2022110208005146500_keac044-B1","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2022110208005146500_keac044-B2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.rdc.2015.04.002","article-title":"The pathogenesis of systemic sclerosis","volume":"41","author":"Stern","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"2022110208005146500_keac044-B3","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3389\/fimmu.2020.00648","article-title":"Interplay between keratinocytes and fibroblasts: a systematic review providing a new angle for understanding skin fibrotic disorders","volume":"11","author":"Russo","year":"2020","journal-title":"Front Immunol"},{"key":"2022110208005146500_keac044-B4","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/rheumatology\/ken370","article-title":"Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer","volume":"47","author":"Aden","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"2022110208005146500_keac044-B5","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1038\/jid.2010.120","article-title":"Epithelial cells promote fibroblast activation via IL-1\u03b1 in systemic sclerosis","volume":"130","author":"Aden","year":"2010","journal-title":"J Invest Dermatol"},{"key":"2022110208005146500_keac044-B6","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/art.41659","article-title":"Dysfunctional keratinocytes increase dermal inflammation in systemic sclerosis. Results from tissue-engineered scleroderma epidermis","volume":"73","author":"Russo","year":"2021","journal-title":". Arthritis Rheumatol"},{"key":"2022110208005146500_keac044-B7","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1038\/jid.2014.253","article-title":"Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9","volume":"134","author":"Nikitorowicz-Buniak","year":"2014","journal-title":"J Invest Dermatol"},{"key":"2022110208005146500_keac044-B8","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/rheumatology\/kex280","article-title":"Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta","volume":"56","author":"McCoy","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2022110208005146500_keac044-B9","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"2022110208005146500_keac044-B10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaci.2020.12.628","article-title":"IL-25 (IL-17E) in epithelial immunology and pathophysiology","volume":"148","author":"Borowczyk","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2022110208005146500_keac044-B11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","article-title":"IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo","volume":"15","author":"Fort","year":"2001","journal-title":"Immunity"},{"key":"2022110208005146500_keac044-B12","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.jid.2016.06.009","article-title":"Keratinocyte-derived IL-17E contributes to inflammation in psoriasis","volume":"136","author":"Senra","year":"2016","journal-title":"J Invest Dermatol"},{"key":"2022110208005146500_keac044-B13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.immuni.2018.03.019","article-title":"An interleukin-25-mediated autoregulatory circuit in keratinocytes plays a pivotal role in psoriatic skin inflammation","volume":"48","author":"Xu","year":"2018","journal-title":"Immunity"},{"key":"2022110208005146500_keac044-B14","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jid.2019.12.013","article-title":"IL-17E (IL-25) and IL-17A differentially affect the functions of human keratinocytes","volume":"140","author":"Borowczyk","year":"2020","journal-title":"J Invest Dermatol"},{"key":"2022110208005146500_keac044-B15","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/all.12633","article-title":"Mutual upregulation of endothelin-1 and IL-25 in atopic dermatitis","volume":"70","author":"Aktar","year":"2015","journal-title":"Allergy"},{"key":"2022110208005146500_keac044-B16","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.jaci.2020.02.026","article-title":"ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation","volume":"145","author":"Leyva-Castillo","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2022110208005146500_keac044-B17","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.jaci.2017.12.1007","article-title":"IL-25 enhances TH17 cell-mediated contact dermatitis by promoting IL-1\u03b2 production by dermal dendritic cells","volume":"142","author":"Suto","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2022110208005146500_keac044-B18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1073\/pnas.1315854111","article-title":"IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis","volume":"111","author":"Hams","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022110208005146500_keac044-B19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s10753-019-01010-4","article-title":"Acute lung injury: IL-17A-mediated inflammatory pathway and its regulation by curcumin","volume":"42","author":"Gouda","year":"2019","journal-title":"Inflammation"},{"key":"2022110208005146500_keac044-B20","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/1535370219843827","article-title":"IL-25 contributes to lung fibrosis by directly acting on alveolar epithelial cells and fibroblasts","volume":"244","author":"Xu","year":"2019","journal-title":"Exp Biol Med (Maywood)"},{"key":"2022110208005146500_keac044-B21","doi-asserted-by":"crossref","first-page":"337ra65","DOI":"10.1126\/scitranslmed.aaf1938","article-title":"Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis","volume":"8","author":"Vannella","year":"2016","journal-title":"Sci Transl Med"},{"key":"2022110208005146500_keac044-B22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.5114\/aoms.2019.84738","article-title":"Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis","volume":"15","author":"Robak","year":"2019","journal-title":"Arch Med Sci"},{"key":"2022110208005146500_keac044-B23","doi-asserted-by":"crossref","first-page":"e105008","DOI":"10.1371\/journal.pone.0105008","article-title":"High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis","volume":"9","author":"Lonati","year":"2014","journal-title":"PLoS One"},{"key":"2022110208005146500_keac044-B24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jid.2019.05.026","article-title":"IL-17A dissociates inflammation from fibrogenesis in systemic sclerosis (scleroderma)","volume":"140","author":"Dufour","year":"2020","journal-title":"J Invest Dermatol"},{"key":"2022110208005146500_keac044-B25","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1111\/jdv.15859","article-title":"Characteristics and roles of extracellular vesicles released by epidermal keratinocytes","volume":"33","author":"Than","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022110208005146500_keac044-B26","first-page":"s35","article-title":"CD4+CD8+ double positive (DP) T cells are characteristic of early fibrotic skin lesions in systemic sclerosis (SSc) (Abstract","volume":"132","author":"Parel","year":"2002","journal-title":"Swiss Med Wkly"},{"key":"2022110208005146500_keac044-B27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/art.37706","article-title":"Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis","volume":"65","author":"Fuschiotti","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022110208005146500_keac044-B28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10067-011-1686-5","article-title":"Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis","volume":"30","author":"Yanaba","year":"2011","journal-title":"Clin Rheumatol"},{"key":"2022110208005146500_keac044-B29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10875-014-0037-0","article-title":"Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels","volume":"34","author":"Vettori","year":"2014","journal-title":"J Clin Immunol"},{"key":"2022110208005146500_keac044-B30","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/art.37859","article-title":"Thymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor \u03b2","volume":"65","author":"Christmann","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022110208005146500_keac044-B31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/annrheumdis-2015-207388","article-title":"Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis","volume":"75","author":"Wohlfahrt","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022110208005146500_keac044-B32","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.20070406","article-title":"IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells","volume":"204","author":"Wang","year":"2007","journal-title":"J Exp Med"},{"key":"2022110208005146500_keac044-B33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2011.03.043","article-title":"Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses","volume":"128","author":"Corrigan","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2022110208005146500_keac044-B34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.matbio.2018.03.001","article-title":"The impaired proteases and anti-proteases balance in Idiopathic Pulmonary Fibrosis","volume":"68\u201369","author":"Menou","year":"2018","journal-title":"Matrix Biol"},{"key":"2022110208005146500_keac044-B35","doi-asserted-by":"crossref","first-page":"2570154","DOI":"10.1155\/2017\/2570154","article-title":"Proteases revisited: roles and therapeutic implications in fibrosis","volume":"2017","author":"Kryczka","year":"2017","journal-title":"Mediators Inflamm"},{"key":"2022110208005146500_keac044-B36","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/annrheumdis-2011-200837","article-title":"Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage","volume":"71","author":"Manetti","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2022110208005146500_keac044-B37","doi-asserted-by":"crossref","first-page":"e109763","DOI":"10.1371\/journal.pone.0109763","article-title":"MMP-12 deficiency attenuates angiotensin II-induced vascular injury, M2 macrophage accumulation, and skin and heart fibrosis","volume":"9","author":"Stawski","year":"2014","journal-title":"PLoS One"},{"key":"2022110208005146500_keac044-B38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/ijms20030619","article-title":"The role of fibrinolytic regulators in vascular dysfunction of systemic sclerosis","volume":"20","author":"Kanno","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2022110208005146500_keac044-B39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2230.2002.01011.x","article-title":"Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis","volume":"27","author":"Kikuchi","year":"2002","journal-title":"Clin Exp Dermatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac044\/43616189\/keac044.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/11\/4558\/46747806\/keac044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/11\/4558\/46747806\/keac044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T08:04:00Z","timestamp":1667376240000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/11\/4558\/6529414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,2,16]]},"published-print":{"date-parts":[[2022,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac044","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,2,16]]}}}